MCAC Amendments Open Up Panel Process, Broaden Scope Of Reviews
This article was originally published in The Gray Sheet
Executive Summary
Evidence report questions for each Medicare Coverage Advisory Committee panel meeting will be made public much earlier in the review process under guidelines updated by the MCAC Executive Committee at a Feb. 22 meeting in Baltimore.
You may also be interested in...
PET Faces A No-Win Situation At MCAC Review Of Alzheimer’s Treatment
The Medicare Coverage Advisory Committee Diagnostic Imaging Panel's rejection of PET imaging for use in treating Alzheimer's disease demonstrates that diagnostic coverage reviews in the future may depend as much on the treatment in question as the diagnostic itself
PET Faces A No-Win Situation At MCAC Review Of Alzheimer’s Treatment
The Medicare Coverage Advisory Committee Diagnostic Imaging Panel's rejection of PET imaging for use in treating Alzheimer's disease demonstrates that diagnostic coverage reviews in the future may depend as much on the treatment in question as the diagnostic itself
PET Faces Uphill Battle Before MCAC After Negative BC/BS TEC Report
The decision of whether to recuse Carole Flamm, MD, from voting in the MCAC Diagnostic Imaging Panel's June 19 meeting on PET imaging for breast cancer will be left up to the panel under direction of the chair, according to HCFA.